Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of the Subdermal Implant "Ultracol"

NCT: NCT07617350 · COMPLETED

NCT IDNCT07617350
StatusCOMPLETED
Start Date2024-07-16
Completion2025-04-10
SponsorEstelab Clinic (NETWORK)
First posted
Last updated

Brief Summary

Study of the effectiveness of the medical device "Intradermal implant, sterile ULTRACOL based on polydioxanone (ULTRA V Co., Ltd., Korea) in the correction of skin contour defects.

Frequently Asked Questions

What is Study of the Subdermal Implant "Ultracol"?

Study of the Subdermal Implant "Ultracol" is a clinical trial registered under NCT07617350. Current status: COMPLETED.

What is the status of NCT07617350?

The current status of NCT07617350 (Study of the Subdermal Implant "Ultracol") is: COMPLETED.

When did Study of the Subdermal Implant "Ultracol" start?

Study of the Subdermal Implant "Ultracol" started on 2024-07-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑